Edition:
United States

Restorbio Inc (TORC.OQ)

TORC.OQ on NASDAQ Stock Exchange Global Select Market

9.87USD
22 Jun 2018
Change (% chg)

$-0.66 (-6.27%)
Prev Close
$10.53
Open
$10.58
Day's High
$10.58
Day's Low
$9.52
Volume
136,079
Avg. Vol
39,700
52-wk High
$21.09
52-wk Low
$7.62

Chart for

About

resTORbio, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases. It focuses on the mechanistic target of rapamycin (mTOR) pathway that regulates aging, and specifically on selective inhibition of the... (more)

Overall

Beta: --
Market Cap(Mil.): $276.82
Shares Outstanding(Mil.): 28.05
Dividend: --
Yield (%): --

Financials

  TORC.OQ Industry Sector
P/E (TTM): -- 29.56 34.14
EPS (TTM): -2.18 -- --
ROI: -- 13.56 13.10
ROE: -- 15.35 15.09

BRIEF-resTORbio Announces Pricing Of Initial Public Offering

* RESTORBIO-ANNOUNCED PRICING OF ITS INITIAL PUBLIC OFFERING OF 5.7 MILLION SHARES OF COMMON STOCK AT A PUBLIC OFFERING PRICE OF $15.00 PER SHARE Source text for Eikon: Further company coverage:

Jan 25 2018

Earnings vs. Estimates